Literature DB >> 6205065

Antigen-specific T contrasuppressor factor in cell-mediated immunity: interactions leading to eradication of the tolerant state.

W Ptak, M Bereta, M Ptak, R K Gershon, D R Green.   

Abstract

Interactions between a T cell-derived, antigen-specific, contrasuppressor factor (TcsF) and immune T cells that block the action of T suppressor factors and allow the transfer of cellular immunity into tolerant recipients are described. Immune T cells from contact-sensitized donors are capable of transferring specific immunity into normal recipients but not into animals rendered tolerant to the specific antigen. Brief exposure of the immune cells to the TcsF enables the effective transfer of immunity into such tolerant recipients. In addition, treated immune cells become resistant to subsequent exposure to T suppressor factor (capable of inhibiting transfer of immunity to normal recipients). A cyclophosphamide-sensitive, I-J+, Ly-2 T transducer cell is required in the immune donor cell population for contrasuppression to be induced by the TcsF plus specific antigen. These cells release an antigen-non-specific contrasuppressive factor capable of rendering immune targets, depleted of transducer cells, resistant to suppression (either by suppressor factor or in the tolerant recipient). The results indicate that contrasuppression in contact sensitivity is antigen specific and that the balance of suppression and contrasuppression determines tolerance vs responsiveness in this system. The symmetrical resemblance of the contrasuppressive interactions to those of suppression in contact sensitivity are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205065

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.

Authors:  A M Friedman; W Ptak; E Brewer; D R Green; P A Reuter; P M Flood
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

2.  Preliminary characterization and distribution of vicia villosa binding cells in human tonsils.

Authors:  B M Almeida; J W Eveson; S J Challacombe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 3.  The role of contrasuppressor T cells in the adoptive transfer of contact sensitivity responses to picryl chloride.

Authors:  W Ptak; A Friedman; M Bereta; J Marcinkiewicz; B Horvat; P Reuter; D R Green; P M Flood
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 4.  Contrasuppression in the mucosal immune system.

Authors:  H Kiyono; D R Green; J R McGhee
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 5.  Role of contrasuppressor T cells in the antibody response to type III pneumococcal polysaccharide.

Authors:  H Braley-Mullen
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 6.  The role of contrasuppression in tumor regression.

Authors:  P M Flood; A Friedman; J Freedman; B Horvat; P Reuter; W Ptak
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

7.  Impairment of contrasuppressor activity in mice infected with the paramyxovirus of Newcastle disease.

Authors:  F Dieli; G Colonna Romano; D Zingone; A Salerno
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 8.  Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation.

Authors:  Thomas Lehner
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

9.  Comparative study of antigen binding T cells separated by Vicia villosa or streptococcal antigen and the effect of HLA class II antigens.

Authors:  T Lehner; T Jones; J Avery
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 10.  Tolerance, suppression and the fetal allograft.

Authors:  Varuna R Aluvihare; Marinos Kallikourdis; Alexander G Betz
Journal:  J Mol Med (Berl)       Date:  2004-12-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.